| Literature DB >> 36028306 |
Anna B Steinkirchner1, Martina E Zimmermann1, Ferdinand J Donhauser1, Alexander Dietl2, Caroline Brandl1,3, Michael Koller4, Julika Loss5,6, Iris M Heid1, Klaus J Stark7.
Abstract
BACKGROUND: To estimate prevalence and incidence of diseases through self-reports in observational studies, it is important to understand the accuracy of participant reports. We aimed to quantify the agreement of self-reported and general practitioner-reported diseases in an old-aged population and to identify socio-demographic determinants of agreement.Entities:
Keywords: AGING; EPIDEMIOLOGY; GENERAL PRACTICE; GERIATRICS; HEALTH STATUS
Year: 2022 PMID: 36028306 PMCID: PMC9554083 DOI: 10.1136/jech-2022-219096
Source DB: PubMed Journal: J Epidemiol Community Health ISSN: 0143-005X Impact factor: 6.286
Figure 1Overview of AugUR study recruitment with number of participants at baseline and in the general practitioner (GP) sub-study. Net response at baseline was 18.1%. For the GP sub-study, 36.7% of GPs responded, resulting in 25.4% of eligible AugUR participants. AugUR; Altersbezogene Untersuchungen zur Gesundheit der Universität Regensburg.
Figure 2Cross-table and terms used for analysing agreement. A template cross-table is exemplified (top left). The rows show the positive and negative self-reports, the columns show the positive and negative GP reports. Also shown are terms used for analysing agreement, including the formula used to calculate Cohen’s kappa. Overall agreement, positive agreement, negative agreement, underreporters and overreporters are further used as percentage by multiplication of the depicted terms by factor 100. GP, general practitioner.
Characteristics of GP substudy participants and AugUR participants
| GP sub-study participants n=589 | AugUR participants n=2321 | |
| Sex | n ( | ||
| Women | 313 (53.1) | 1219 (52.5) |
| Men | 276 (46.9) | 1102 (47.5) |
| Age | median (IQR) | 79.0y (75.5–82.6y) | 78.9y (75.7–82.6y) |
| Living with partner | n ( | ||
| No | 265 (45.0) | 954 (41.1) |
| Yes | 324 (55.0) | 1367 (58.9) |
| Education | n ( | ||
| ≤8 years | 309 (53.1) | 1173 (50.9) |
| >8 years | 273 (46.9) | 1130 (49.1) |
| Most recent interview time point | n ( | ||
| 2013–2015 (AugUR-1-BL) | 72 (12.2) | 322 (13.9) |
| 2016–2018 (AugUR-1-F1) | 146 (24.8) | 641 (27.6) |
| 2017–2019 (AugUR-2-BL) | 340 (57.7) | 1244 (53.6) |
| 2019–2020 (AugUR-1-F2) | 31 (5.3) | 114 (4.9) |
| Median time difference to GP substudy | ||
| All | 2.66y | |
| AugUR-1-BL | 5.86y | |
| AugUR-1-F1 | 2.81y | |
| AugUR-2-BL | 2.09y | |
| AugUR-1-F2 | 0.86y | |
Shown are the numbers for 589 GP substudy participants and all 2321 participants of AugUR, which gave consent and valid information to contact their GPs. Absolute numbers and percentages are shown. y=years; AugUR-1-BL=baseline visit AugUR-1 cohort; AugUR-1-F1=follow-up-1 visit AugUR-1 cohort; AugUR-2-BL=baseline visit AugUR-2 cohort; AugUR-1-F2=follow-up-2 visit AugUR-1 cohort. Comparisons between GP-substudy participants and non-participants are presented in online supplemental table 5.
AugUR, Altersbezogene Untersuchungen zur Gesundheit der Universität Regensburg; GP, general practitioner.
Frequencies of chronic diseases in self-reports and GP reports and parameters for agreement
|
| Frequencies % (n) | Parameters of agreement | ||||||
| Self-reports | GP reports | Overall agreement % (n) | Overreporters% (n) | Underreporters % (n) | Positive agreement % | Negative agreement % | Cohen’s kappa | |
| Hypertension (n=570) | 74.2 (423) | 76.7 (437) | 81.1 (462) | 35.5 (47) | 14.0 (61) | 87.4 | 61.4 | 0.50 |
| Diabetes (n=586) | 24.1 (141) | 28.3 (166) | 90.6 (531) | 3.6 (15) | 24.1 (40) | 82.1 | 93.6 | 0.76 |
| Myocardial infarction (n=577) | 9.7 (56) | 6.6 (38) | 93.8 (541) | 5.0 (27) | 23.7 (9) | 61.7 | 96.6 | 0.58 |
| Heart failure (n=577) | 19.1 (110) | 16.5 (95) | 78.3 (452) | 14.5 (70) | 57.9 (55) | 39.0 | 86.8 | 0.26 |
| Stroke (n=581) | 9.1 (53) | 7.4 (43) | 93.8 (545) | 4.3 (23) | 30.2 (13) | 62.5 | 96.6 | 0.59 |
| Kidney disease (n=581) | 28.9 (168) | 19.3 (112) | 68.3 (397) | 25.6 (120) | 57.1 (64) | 34.3 | 79.1 | 0.15 |
| Cancer (n=584) | 26.9 (157) | 23.6 (138) | 87.2 (509) | 10.5 (47) | 20.3 (28) | 74.6 | 91.4 | 0.66 |
| Asthma (n=519) | 10.0 (52) | 6.7 (35) | 92.9 (482) | 5.6 (27) | 28.6 (10) | 57.7 | 96.1 | 0.53 |
| Bronchitis/COPD (n=514) | 8.9 (46) | 6.0 (31) | 90.5 (465) | 6.6 (32) | 54.8 (17) | 36.4 | 94.8 | 0.31 |
| Rheumatoid arthritis (n=511) | 13.5 (69) | 5.1 (26) | 86.1 (440) | 11.8 (57) | 53.8 (14) | 25.3 | 92.3 | 0.19 |
| Arthrosis (n=537) | 66.9 (359) | 44.9 (241) | 56.4 (303) | 59.5 (176) | 24.1 (58) | 61.0 | 50.6 | 0.16 |
Hypertension, diabetes, myocardial infarction, heart weakness, stroke, kidney disease, cancer (excluding white skin cancer), lung diseases and musculoskeletal diseases were addressed. Self-reports and GP reports, overall agreement, over-reporters and under-reporters are shown as totals and in percentages. Specific positive and negative agreement is shown in percentages. All parameters were calculated as shown in figure 2. Total n varies due to missing values.
COPD, chronic obstructive pulmonary disease; GP, general practitioner.
Multiple regression models analysing the association of overall agreement between self-reports and GP reports with independent variables
| Overall agreement for | Variable | OR | CI (95%) | P value |
| Hypertension | Sex | men | 0.702 | 0.445 to 1.107 | 0.128 |
| Age | per 1 year | 0.999 | 0.957 to 1.043 | 0.960 | |
| Living w. partner | yes | 0.926 | 0.581 to 1.477 | 0.748 | |
| Education | >8 y | 0.840 | 0.549 to 1.284 | 0.420 | |
| Diabetes | Sex | men | 1.021 | 0.550 to 1.895 | 0.947 |
| Age | per 1 year | 0.968 | 0.915 to 1.024 | 0.261 | |
| Living w. partner | yes | 1.736 | 0.931 to 3.235 | 0.083 | |
| Education | >8 y | 1.173 | 0.661 to 2.081 | 0.586 | |
| Myocardial infarction | Sex | men | 0.518 | 0.246 to 1.092 | 0.084 |
|
|
|
|
| |
| Living w. partner | yes | 1.460 | 0.694 to 3.070 | 0.319 | |
| Education | >8 y | 1.033 | 0.522 to 2.047 | 0.925 | |
| Heart failure | Sex | men | 0.808 | 0.522 to 1.249 | 0.338 |
| Age | per 1 year | 0.965 | 0.927 to 1.005 | 0.083 | |
| Living w. partner | yes | 1.492 | 0.961 to 2.316 | 0.075 | |
| Education | >8 y | 0.866 | 0.579 to 1.295 | 0.484 | |
| Stroke |
|
|
|
|
|
|
|
|
| |
| Living w. partner | yes | 1.078 | 0.509 to 2.286 | 0.844 | |
| Education | >8 y | 1.048 | 0.528 to 1.078 | 0.893 | |
| Kidney disease |
|
|
|
|
| Age | per 1 year | 0.965 | 0.931 to 1.000 | 0.051 | |
| Living w. partner | yes | 1.276 | 0.863 to 1.886 | 0.222 | |
| Education | >8 y | 1.157 | 0.810 to 1.653 | 0.424 | |
| Cancer |
|
|
|
|
| Age | per 1 year | 1.011 | 0.961 to 1.065 | 0.663 | |
| Living w. partner | yes | 0.907 | 0.526 to 1.566 | 0.727 | |
|
|
|
|
| |
| Asthma | Sex | men | 1.294 | 0.628 to 2.668 | 0.484 |
| Age | per 1 year | 1.017 | 0.948 to 1.090 | 0.642 | |
| Living w. partner | yes | 0.688 | 0.326 to 1.453 | 0.327 | |
| Education | >8 y | 1.864 | 0.925 to 3.755 | 0.082 | |
| Bronchitis/COPD | Sex | men | 0.869 | 0.454 to 1.662 | 0.671 |
| Age | per 1 year | 0.963 | 0.909 to 1.021 | 0.204 | |
| Living w. partner | yes | 0.788 | 0.403 to 1.539 | 0.485 | |
| Education | >8 y | 0.839 | 0.461 to 1.527 | 0.565 | |
| Rheumatoid arthritis |
|
|
|
|
| Age | per 1 year | 0.977 | 0.929 to 1.028 | 0.369 | |
| Living w. partner | yes | 0.693 | 0.395 to 1.214 | 0.200 | |
| Education | >8 y | 0.764 | 0.458 to 1.276 | 0.304 | |
| Arthrosis | Sex | men | 1.158 | 0.797 to 1.682 | 0.443 |
| Age | per 1 year | 0.993 | 0.959 to 1.027 | 0.675 | |
| Living w. partner | yes | 0.866 | 0.593 to 1.263 | 0.454 | |
| Education | >8 y | 1.155 | 0.818 to 1.632 | 0.413 |
Each model for the respective disease (hypertension, diabetes, myocardial infarction, heart failure, stroke, kidney disease, cancer, lung diseases and musculoskeletal diseases) was adjusted for all four independent variables (sex, age, living status and education level). ORs with 95% CIs and p-value are shown. Significantly associated characteristics are shown in bold letters. Independent variables were coded 0/1, so numbers show the disease’s OR for men versus women, being 1 year older, living with a partner versus without and having>8 y of education versus less.
COPD, chronic obstructive pulmonary disease; GP, general practitioner.
Selection of literature: kappa values and characteristics for studies evaluating kappa statistics for agreement
| Authors | Ref | Cohort characteristics | Age group | Kappa* | ||||||||||
| HYP | DM | MI | HF | Stroke | KD | Cancer | Asthma | CB/COPD | RA | Arthrosis | ||||
| Camplain |
| Prospective cohort recruited from US communities (n=11 846) | 6083y | 0.39 | ||||||||||
| Okura |
| Population-based prospective cohort to study cardiac function (n=2307) | Mean: 61y | 0.75 | 0.76 | 0.80 | 0.46 | 0.71 | ||||||
| Hansen |
| Multimorbid participants recruited from GP practices (n=3189) | mean: 74.4y | 0.56 | 0.80 | 0.24 | 0.55 | 0.50 | 0.61§ | 0.27 | 0.29 | |||
| van den Akker |
| Prospective, dynamic cohort recruited from healthcare centres (n=2893) | Mean: 68y | 0.86 | 0.57 | 0.52 | 0.60 | 0.58§ | 0.17 | |||||
| Kriegsman |
| Independently living participants drawn from population registries (n=2380) | 5585y | 0.85 | 0.56 | 0.66 | 0.63§ | 0.35 | ||||||
| Merzenich |
| Breast cancer patients recruited from hospitals (n=1212) | Mean: 65.9y | 0.71 | 0.78 | 0.54 | 0.34 | 0.61 | 0.40 | 0.57 | ||||
| Barber |
| Population-based cohort, recruited from three GP practices (n=5889) | ≥50y | 0.67 | 0.90 | |||||||||
| Englert |
| Patients with primary hypercholesterinaemia enrolled in primary care centres (n=7640) | Mean: 61y | 0.69 | 0.89 | 0.55 | 0.29 | 0.44 | ||||||
| Merkin |
| End-stage renal disease patients recruited from dialysis clinics (n=965) | Mean: 58y | 0.20 | 0.93 | 0.55 | 0.47 | 0.59 | 0.67 | 0.20 | ||||
| Muggah |
| Sample of community dwelling general population (n=85 549) | ≤20y | 0.66 | 0.80 | 0.48 | 0.33 | 0.36 | 0.55 | 0.29 | ||||
| Leikauf |
| Participants randomly recruited from outpatient practices (n=323) | Mean: 73.1y | 0.59 | 0.94 | 0.66 | ||||||||
| Corser |
| Hospitalised Acute Coronary Syndrome patients (n=525) | Mean: 59.7y | 0.80 | 0.63 | 0.09 | 0.54 | 0.47 | 0.33 | 0.43 | 0.07 | |||
| Teh |
| Octogenarians of general population (n=878) | Mean: 82.3y†, 84.6y‡ | 0.44 | 0.45 | 0.19 | 0.43 | |||||||
| This study | Mobile elderly general population drawn from population registries (n=589) | Mean: 79.0y | 0.50 | 0.76 | 0.58 | 0.26 | 0.59 | 0.15 | 0.66 | 0.53 | 0.31 | 0.19 | 0.16 | |
We listed the literature reference, the author, a concise summary describing the study cohort and an age reference. Mean age was used if available, otherwise we depicted the study cohort’s age range. Kappa values shown for HYP, DM, MI, HF, KD, CB)/COPD, RA, arthrosis.
*Highest reported kappa values for each disease were used, as they may vary due to different disease-definitions within a study.
† Age evaluated for Māori and
‡Non-Māori participants in New Zealand;
§Evaluated asthma and COPD as one category or as ‘chronic lung disease’.
CB, chronic bronchitis; COPD, chronic obstructive pulmonary disease ; DM, diabetes; HF, heart failure; HYP, hypertension; KD, stroke, kidney disease; MI, myocardial infarction; RA, rheumatoid arthritis; REF, literature reference.